Quantitative and targeted proteomics-based identification and validation of drug efficacy biomarkers

T Masuda, A Mori, S Ito, S Ohtsuki - Drug Metabolism and …, 2021 - Elsevier
Proteomics refers to the large-scale study of proteins, providing comprehensive and
quantitative information on proteins in tissue, blood, and cell samples. In many studies …

Disentangling biomolecular corona interactions with cell receptors and implications for targeting of nanomedicines

A Aliyandi, IS Zuhorn, A Salvati - Frontiers in Bioengineering and …, 2020 - frontiersin.org
Nanoparticles are promising tools for nanomedicine in a wide array of therapeutic and
diagnostic applications. Yet, despite the advances in the biomedical applications of …

Inhibition of clathrin‐mediated endocytosis by knockdown of AP‐2 leads to alterations in the plasma membrane proteome

D Tobys, LM Kowalski, E Cziudaj, S Müller, P Zentis… - Traffic, 2021 - Wiley Online Library
In eukaryotic cells, clathrin‐mediated endocytosis (CME) is a central pathway for the
internalization of proteins from the cell surface, thereby contributing to the maintenance of …

Subcellular trafficking and transcytosis efficacy of different receptor types for therapeutic antibody delivery at the blood‒brain barrier

MR Holst, NM de Wit, B Ozgür, A Brachner… - Fluids and Barriers of …, 2023 - Springer
Here, we report an experimental setup to benchmark different receptors for targeted
therapeutic antibody delivery at the blood–brain barrier. We used brain capillary endothelial …

[HTML][HTML] Cell surface biotinylation to identify the receptors involved in nanoparticle uptake into endothelial cells

A Aliyandi, C Reker-Smit, IS Zuhorn, A Salvati - Acta Biomaterialia, 2023 - Elsevier
Targeted drug delivery requires–among others-specific interaction of nanocarriers with cell
surface receptors enabling efficient internalization into the targeted cells. Thus, identification …

Proteome of the luminal surface of the blood–brain barrier

JJ Hill, AS Haqqani, DB Stanimirovic - Proteomes, 2021 - mdpi.com
Interrogation of the molecular makeup of the blood–brain barrier (BBB) using proteomic
techniques has contributed to the cataloguing and functional understanding of the proteins …

The proteome of the blood–brain barrier in rat and mouse: highly specific identification of proteins on the luminal surface of brain microvessels by in vivo glycocapture

TL Tremblay, W Alata, J Slinn, E Baumann… - Fluids and Barriers of …, 2024 - Springer
Background The active transport of molecules into the brain from blood is regulated by
receptors, transporters, and other cell surface proteins that are present on the luminal …

Identifying molecular tags selectively retained on the surface of brain endothelial cells to generate artificial targets for therapy delivery

GM Porro, I Lorandi, X Liu, K Kataoka… - Fluids and Barriers of …, 2023 - Springer
Current strategies to identify ligands for brain delivery select candidates based on
preferential binding to cell-membrane components (CMC) on brain endothelial cells (EC) …

Advances in sample preparation for membrane proteome quantification

T Masuda, S Ito, S Ohtsuki - Drug Discovery Today: Technologies, 2021 - Elsevier
Membrane proteins mediate various biological processes. Most drugs commercially
available target proteins on the cell surface. Therefore, proteomics of plasma membrane …

Effect of Apolipoprotein E isoforms on the Abundance and Function of P-glycoprotein in Human Brain Microvascular Endothelial Cells

E Kreutzer, JL Short, JA Nicolazzo - Pharmaceutical Research, 2024 - Springer
Abstract Background Individuals with Alzheimer's disease (AD) often require many
medications; however, these medications are dosed using regimens recommended for …